Antibody therapy for modulating function of intestinal receptors and methods of treating diabetes and obesity
US8268971B2 · kind B2 · utility
0Cited by
6References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 14, 2010 |
| Grant date | Sep 18, 2012 |
| Priority date | — |
| Expiry date | Jan 14, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides pharmaceutical compositions formulated for direct delivery to the GI tract of a patient comprising an antibody specific for a target apical intestinal receptor. The present invention further provides methods of treating diseases and conditions in a patient comprising administering directly to the GI tract of the patient, compositions of the present invention wherein modulation of the target apical intestinal receptor by the antibody treats the condition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.